There was no local or nation-wide data on the patterns of Gastrointestinal Stromal Tumors (GISTs) in Iraq. This study was undertaken to determine the clinical and pathologic characteristics and risk stratification of GISTs in Iraqi patients over a nine years' period. This is a retrospective descriptive study. Medical notes and histopathological reports of patients with confirmed diagnosis of GIST between January 2007 and August 2015 were reviewed for age, gender, tumor location, CD117 status, tumor stage, and National Institutes of Health (NIH) risk classification. Fortyseven patients were included in the study. Mean age at time of diagnosis was 57 years (range 29 to 85 years), and male to female ratio was 1:1. Most common sites of involvement of GISTs were stomach (21/47), and jejunum/ ileum (16/47).
Introduction
Despite being the most common mesenchymal tumors of the gastrointestinal (GI) tract, the gastrointestinal stromal tumors (GISTs) account for only 0.2% of all GI tumors.
[1] The current consensus is that the GISTs originate from the interstitial cells of Cajal, or from their precursors [2] . The annual incidence of GIST is Stomach is the most frequent site of GIST, followed by small intestine and colorectal area [3] . GIST is reported to metastasize most often to the liver and peritoneum, and rarely to lymph nodes, bone, lung and soft tissues [4] . 
Methodology
The study was an observational, The pattern and sites of metastasis were studied. The percentage of CD117 positivity was collected to assess the sensitivity of this test in diagnosis of GIST among our patients. All data was described as numbers and percentages.
Microsoft excel was used to compile the data. Since this was a descriptive study, no statistical tests were applied.
Results
A total of 47 cases of GIST were registered in the BOC registry during the study period. Out of the 47 patients in our study, risk stratification based on NIH consensus criteria was possible for 41 patients. These results are presented in Table 2 . Most (61%) of the cases were classified under 'high risk'. As reported from other studies [15, 16] liver was the most common site of metastasis in our patients. However, pulmonary metastases, which have been described as 'rare' in GISTs [17] , and a sign of advanced disease [4] , was the second most common site of metastases in our study. This may indicate that at presentation, a higher proportion of GIST patients from this region are already having advanced disease.
Further studies are required to investigate more into this pattern of metastasis in GIST patients from this region.
In our study, 33 out of 36 (92%) were strongly positive for CD117 by immunohistochemistry. The proportion of CD117 positivity in our study was similar to that in previously reported studies, which report a CD117 positivity ranging from 86.6 to 100 % from Asian studies [14, 16, 18] , and over 95% from
Western studies [19, 20] . Further, studies are required to confirm the CD117 positivity in our country. 
